Starcad-Beta 12.5 Tablet ER
Marketer
Lupin Ltd
Salt Composition
Metoprolol Succinate (11.8mg)
Overview Starcad-Beta 12.5 Tablet ER
Betasol ER 12.5mg tablets are beta-adrenergic blocking agents indicated for managing hypertension, angina pectoris, and cardiac arrhythmias. This medication also aids in migraine prophylaxis and reducing the risk of recurrent myocardial infarction and stroke. Betasol ER 12.5mg may be administered independently or in conjunction with other therapies, with dosage tailored to individual needs and condition severity. Consistent daily dosing, regardless of meals, maximizes efficacy. Therapeutic benefits may take several weeks to fully manifest, often requiring lifelong use. Continued use is crucial, even in the absence of noticeable symptoms, as discontinuation may exacerbate underlying conditions. Common, typically transient, adverse effects include fatigue, cephalgia, depressive mood, bowel looseness, skin rash, bradycardia, vertigo, and nausea. Hypotension and dyspnea are less frequent possibilities. Gradual dose escalation minimizes adverse reactions. Report any persistent or troubling side effects to your physician. Pre-existing hepatic impairment, bradycardia, significant circulatory compromise, decompensated heart failure, or hypotension necessitate prior medical consultation. Similarly, pregnant or lactating individuals should seek professional advice before commencing treatment. Individual suitability requires physician assessment. Regular blood pressure monitoring is essential to evaluate treatment response. Alcohol consumption should be limited due to potential exacerbation of adverse effects.
Primary Ingredients of Starcad-Beta 12.5 Tablet ER
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Starcad-Beta 12.5 Tablet ER
Managing angina pectoris (chest discomfort from heart issues)|Correcting cardiac arrhythmias|Preventing myocardial infarction|Controlling hypertension (elevated blood pressure)|Preventing migraine headaches
Major Benefits of Starcad-Beta 12.5 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Starcad-Beta 12.5 Tablet ER. Swallow the tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistency in timing is recommended. For optimal absorption, avoid consuming Starcad-Beta 12.5 Tablet ER with meals high in fat, including foods like olive oil, nuts and seeds (especially Brazil nuts), dark chocolate, butter, and red meat.
Common Side effects of Starcad-Beta 12.5 Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Starcad-Beta 12.5 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Starcad-Beta 12.5 Tablet ER. Swallow the tablet whole; do not chew, crush, or break it. This medication can be taken with or without food, but consistency in timing is recommended. Minimize consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and meat while taking Starcad-Beta 12.5 Tablet ER.
How Starcad-Beta 12.5 Tablet ER works:
Extended-release Starcad-Beta 12.5mg tablets are a cardioselective beta-adrenergic blocker designed to reduce heart rate and improve the heart's pumping efficiency, providing sustained therapeutic effects.
SAFETY ADVICE
AlcoholUNSAFE
Combining Starcad-Beta 12.5 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Starcad-Beta 12.5 Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against the risks before prescribing this medication. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Starcad-Beta 12.5 mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Extended-release Starcad-Beta 12.5 mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Starcad-Beta 12.5 mg tablets are considered safe for individuals with impaired renal function. No modification of the Starcad-Beta 12.5 mg ER tablet dosage is necessary.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Starcad-Beta 12.5 Extended-Release tablets. Dosage modification of Starcad-Beta 12.5 Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Starcad-Beta 12.5 Tablet ER :
Should you forget to take a Starcad-Beta 12.5 Tablet ER, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Starcad-Beta 12.5 Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |






